Carfilzomib Alternatives Compared
| Carfilzomib | Abecma (idecabtagene vicleucel) | Carvykti (ciltacabtagene autoleucel) |
|
|---|
| Carfilzomib | Abecma (idecabtagene vicleucel) | Carvykti (ciltacabtagene autoleucel) |
|
|---|---|---|---|
|
Prescription only
Prescribed for Multiple Myeloma. Carfilzomib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Multiple Myeloma. Abecma may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Multiple Myeloma. Carvykti may also be used for purposes not listed in this medication guide. |
Related suggestions Multiple Myeloma
|
| More about Carfilzomib | More about Abecma (idecabtagene vicleucel) | More about Carvykti (ciltacabtagene autoleucel) | |
| Ratings & Reviews | |||
|
Carfilzomib has an average rating of 6.6 out of 10 from a total of 5 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 20% reported a negative effect. |
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||
|
View all Carfilzomib side effects |
View all Abecma side effects |
View all Carvykti side effects |
|
| Drug Class | |||
| Generic Availability | |||
|
N/A |
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | |||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | |||
|
N/A |
|
|
|
| Brand Names | |||
| Kyprolis |
N/A |
N/A |
|
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||
|
1 hour |
N/A |
N/A |
|
| CSA Schedule 1 View glossary of CSA terms | |||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | |||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
| Drug Interactions | |||
|
A total of 360 drugs are known to interact with Carfilzomib:
|
A total of 298 drugs are known to interact with Abecma:
|
A total of 308 drugs are known to interact with Carvykti:
|
|
| Alcohol/Food/Lifestyle Interactions | |||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Disease Interactions | |||
| First Approval Date | |||
|
N/A |
N/A |
N/A |
|
| WADA Class View classifications | |||
|
N/A |
N/A |
N/A |
|
| More Information | |||
| Patient Resources | |||
| Professional Resources | |||
| Related Treatment Guide | |||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.